Primary dermal melanoma: Distinct immunohistochemical findings and clinical outcome compared with nodular and metastatic melanoma

Archives of Dermatology

Volumn 144, Issue 1, 2008, Pages 49-56

  Cassarino, David S ^a,b,d,e   Cabral, Erik S ^a   Kartha, Reena V ^a   Swetter, Susan M ^b,c  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^c VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; PODOPLANIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COHORT ANALYSIS; COMPARATIVE STUDY; CUTANEOUS METASTATIC MELANOMA; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MELANOMA; PATHOLOGY; PRIMARY DERMAL MELANOMA; PRIMARY NODULAR MELANOMA; PRIORITY JOURNAL; SATELLITE METASTASIS; SOLID TUMOR; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; COHORT STUDIES; DERMIS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MELANOMA; MIDDLE AGED; NEOPLASM METASTASIS; PROGNOSIS; RISK ASSESSMENT; SEX DISTRIBUTION; SKIN NEOPLASMS; SUBCUTANEOUS TISSUE; SURVIVAL ANALYSIS;

EID: 38549084827     PISSN: 0003987X     EISSN: 0003987X     Source Type: Journal    
DOI: 10.1001/archdermatol.2007.16     Document Type: Article

References (19)

1. Swetter SM, Ecker PM, Johnson DL, Harvell JD. Primary dermal melanoma: a distinct subtype of melanoma. Arch Dermatol. 2004;140(1):99-103.
2. Bowen GM, Chang AE, Lowe L, Hamilton T, Patel R, Johnson TM. Solitary melanoma confined to the dermal and/or subcutaneous tissue: evidence for revisiting the staging classification. Arch Dermatol. 2000;136(11):1397-1399.
3. Giuliano AE, Moseley HS, Morton DL. Clinical aspects of unknown primary melanoma. Ann Surg. 1980;191(1):98-104.
4. Schlagenhauff B, Stroebel W, Ellwanger U, et al. Metastatic melanoma of unknown primary origin shows prognostic similarities to regional metastatic melanoma: recommendations for initial staging examination. Cancer. 1997;80(1):60-65.
5. Anbari KK, Schuchter LM, Bucky LP, et al. Melanoma of unknown primary site: presentation, treatment, and prognosis: a single institution study. Cancer. 1997;79(9):1816-1821.
6. Balch CM, Buxaid AC, Soong S-J, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol. 2001;19(16):3635-3648.
7. Balch CM, Soong S-J, Atkins MB, et al. An evidence-based staging system for cutaneous melanoma. CA Cancer J Clin. 2004;54(3):131-149.
8. Guerriere-Kovach PM, Hunt EL, Patterson JW, Glembocki DJ, English JC III, Wick MR. Primary melanoma of the skin and cutaneous melanomatous metastases: comparative histologic features and immunophenotypes. Am J Clin Pathol. 2004;122(1):70-77.
9. Potti A, Hille R, Koch M. Immunohistochemical determination of HER-2/neu in malignant melanoma. Anticancer Res. 2003;23(5A):4067-4069.
10. Granter SR, McKee PH, Calonje E, Mihm MC Jr, Busam K. Melanoma associated with blue nevus and melanoma mimicking cellular blue nevus: a clinicopathological study of 10 cases on the spectrum of so-called "malignant blue nevus." Am J Surg Pathol. 2001;25(3):316-323.
11. Connelly J, Smith JL. Malignant blue nevus. Cancer. 1991;67(10):2653-2657.
12. Goldenhersh MA, Savin RC, Barnhill RL, Stenn KS. Malignant blue nevus: case report and literature review. J Am Acad Dermatol. 1988;19(4):712-722.
13. Woodruff JM, Kourea HP, Louis DN, Scheithauer BW. Malignant peripheral nerve sheath tumor (MPNST). In: Kleihues P, Cavenee WK, eds. World Health Organization Classification of Tumors, Pathology and Genetics: Tumors of the Nervous System. Lyon, France: IARC Press; 2000:172-174.
14. Sciot R, Speleman F. Clear cell sarcoma of soft tissue. In: Fletcher CDM, Unni KK, Mertens F, eds. World Health Organization Classification of Tumors, Pathology and Genetics: Tumors of Soft Tissue and Bone. Lyon, France: IARC Press; 2002:211-212.
15. Boyle JL, Haupt HM, Stern JB, Multhaupt HA. Tyrosinase expression in malignant melanoma, desmoplastic melanoma, and peripheral nerve tumors. Arch Pathol Lab Med. 2002;126(7):816-822.
16. Deyrup AT, Alhof P, Zhou M, et al. Paraganglioma-like dermal melanocytic tumor: a unique entity distinct from cellular blue nevus, clear cell sarcoma, and cutaneous melanoma. Am J Surg Pathol. 2004;28(12):1579-1586.
17. Dadras SS, Paul T, Bertoncini J, et al. Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival. Am J Pathol. 2003;162(6):1951-1960.
18. Dadras SS, Lange-Asschenfeldt B, Velasco P, et al. Tumor lymphangiogenesis predicts melanoma metastasis to sentinel lymph nodes. Mod Pathol. 2005;18(9):1232-1242.
19. Klein WM, Wu BP, Zhao S, et al. Increased expression of stem cell markers in malignant melanoma. Mod Pathol. 2007;20(1):102-107.